CHHE (China Health Industries Holdings) Current Ratio: 0.04 (As of Mar. 2024)


CHHE China Health Industries Holdings Inc CHHE
20 GF Score
Price $0.00
View Full Analysis

What is China Health Industries Holdings Current Ratio?

China Health Industries Holdings CHHE 20 Current Ratio is 0.04 as of Mar. 2024. GuruFocus rates CHHE with a GF Score™ of 20/100.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. China Health Industries Holdings's current ratio for the quarter that ended in Mar. 2024 was 0.04.

China Health Industries Holdings has a current ratio of 0.04. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If China Health Industries Holdings has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for China Health Industries Holdings's Current Ratio or its related term are showing as below:

CHHE's Current Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2
* Ranked among companies with meaningful Current Ratio only.

China Health Industries Holdings  (OTCPK:CHHE) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


China Health Industries Holdings Current Ratio Related Terms


China Health Industries Holdings Current Ratio Historical Data

* Premium members only.

The historical data trend for China Health Industries Holdings's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Health Industries Holdings Current Ratio Chart

China Health Industries Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.48 4.88 5.24 5.74 6.86

China Health Industries Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.68 6.86 6.82 0.04 0.04

CHHE vs BIOE, CRYM, TXMD: Current Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Health Industries Holdings Current Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's Current Ratio distribution charts can be found below:

* The bar in red indicates where China Health Industries Holdings's Current Ratio falls into.


CHHE
20GF Score
China Health Industries Holdings Inc CHHE
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Health Industries Holdings Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

China Health Industries Holdings's Current Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Current Ratio (A: Jun. 2023 )=Total Current Assets (A: Jun. 2023 )/Total Current Liabilities (A: Jun. 2023 )
=40.97/5.973
=6.86

China Health Industries Holdings's Current Ratio for the quarter that ended in Mar. 2024 is calculated as

Current Ratio (Q: Mar. 2024 )=Total Current Assets (Q: Mar. 2024 )/Total Current Liabilities (Q: Mar. 2024 )
=0.248/6.529
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 0.04 mean?
China Health Industries Holdings (CHHE) has a Current Ratio of 0.04 as of Mar. 2024.
Is China Health Industries Holdings' Current Ratio too high?
China Health Industries Holdings' current Current Ratio is 0.04. The Drug Manufacturers industry median Current Ratio is 2.00. China Health Industries Holdings' value of 0.04 is 98% below this industry median. Overall, China Health Industries Holdings has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does China Health Industries Holdings' Current Ratio compare to BIOE and CRYM?
China Health Industries Holdings' Current Ratio of 0.04 can be compared against companies in the Drug Manufacturers industry. The industry median Current Ratio is 2.00. China Health Industries Holdings' value of 0.04 is 98% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Health Industries Holdings's current Current Ratio of 0.04 is 98% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Industries Holdings's current Current Ratio is 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Industries Holdings stock overvalued right now?
China Health Industries Holdings (CHHE) has a current Current Ratio of 0.04. The current Current Ratio is 0.04 and 98% below the Drug Manufacturers industry median of 2.00. China Health Industries Holdings' overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For China Health Industries Holdings (CHHE), the current Current Ratio is 0.04 as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

China Health Industries Holdings Business Description

Address 3199-1 Longxiang Road, Songbei District, Heilongjiang Province, Harbin, CHN, 150028
China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.
20GF Score

Get the complete analysis for CHHE

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price